ClinicalTrials.gg
CompletedNCT04401514RocingICUUpdated Mar 19, 2024

Does Rocking Charis Calm Delirious Patients in the Intensive Care Unit

An interventional study of Rocking chair therapy in Delirium, sponsored by Scandinavian Critical Care Trials Group. Completed at 1 site in Denmark. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2024-03-19.

Sponsored by Scandinavian Critical Care Trials Group · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
152
Allocation
Randomized
Ages
18 Years to 110 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 26 studies in Delirium with a site in Denmark — 1 open to participants now, 3 under way, 1 of them phase 3. Delirium · Denmark.

Enrollment
7th of 12
152 · median 175
Started
2020
with 2 others
No phase
8 of 26
1 open now
Registered
16th of 26
by date

Among the 26 studies in Delirium with a site in Denmark, this one is the 7th largest by enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2020, is one of 8 with no phase, and was the 16th registered.

Delirium

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

Browse Delirium studies →

Open to participants now

1 of the 26 studies in Delirium with a site in Denmark is open now. Recruiting first, the newest first:

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.

This study: 18 Years to 110 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Delirium with a site in Denmark, or all of them as a file.
02

Study summary

Background: Delirium among patients admitted to an ICU is a common condition associated with increased morbidity and mortality. To this point no evidence-based prevention or treatment exist for delirium. Non-pharmacological interventions such as early mobilization and systematic bundle of care have been suggested to decrease the number of days of delirium. So far there exist no studies exploring if delirious patients benefit or not when mobilized to a rocking chair with music therapy.

Objectives: To assess if rocking chair therapy can decrease the burden of delirium in adult, critical ill patients admitted to an ICU.

Design: A clinical initiated multicenter randomized non-blinded trial, of delirious patients mobilized to a rocking chair versus no rocking chair.

Inclusion and exclusion criteria: Inclusion criteria: Adult intensive care patients (18 years and above) diagnosed with delirium with a validated screening tool. Exclusion criteria: if the patient is evaluated not to be mobilized to a rocking chair and expressing discomfort and do not wish to be mobilized, a patient with critical illness neuropati, patients with lever coma, patient in ECM treatment, patients that are mentally permanently incompetent, not receiving active life support if needed, weight more that 130 kg, if informed consent cannot be obtained, if the patient is admitted because of suicide attempt and is the patient have delirium tremens.

Intervention: The experimental intervention is a 20 min. long rocking chair with music therapy. Control intervention is also transferred to the rocking chair, but the therapy program will not be turned on. Standardized pharmacological and non-pharmacological interventions for delirium will continue for both groups. Delirium and consciousness will be evaluated twice a day.

Outcomes: Primary outcome: number of days alive without coma and delirium in the ICU. Secondary outcome: Number of days admitted to the ICU and number of patients with at least one difference in RASS score before end after the experimental intervention.

Trial size: A power calculation have estimated that a total number of 76 patients with delirium should be included in each study group.

Time schedule: We estimate that the inclusion period and follow up will as long as 1 year from the time the first patient is randomized.

Amendment's protocol Agreed by the project group August 22nd 2022, we will do an additional 90-day follow-up of all-cause mortality. This was agreed before the project group or statistician had access to the randomisation key and intervention data, and before any statistical analysis was started.

Read the detailed description

The intervention is a 30 min long transfer to a rocking chair with music cure therapy. For the intervention group, the intervention will be turned on and for the control, the rocking and music function will not be turned on.

03

Conditions studied

  • Delirium

Browse trials for

04

Who can participate

Ages eligible
18 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • admitted to ICU
  • positive delirium evaluation with CAM-ICU or ICDSC

Exclusion criteria

Exclusion Criteria:

  • if the patient is evaluated not to be mobilized to a rocking chair
  • expressing discomfort and do not wish to be mobilized
  • patients with critical illness neuropathy
  • patients with levercoma
  • patient in ECOM (exstracorporel membrane oxygenation) treatment
  • patients that are mentally permanently incompetent
  • patients not receiving active life support if needed
  • patients that weight more than 130 kg
  • patients were cannot be obtained
  • patients admitted because of suicide attempt
  • patients with delirium tremens
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
152 participants (actual)

Study arms

  • Experimental
    Experiemntal intervention

    The experimental intervention is a 20 min. long rocking chair with music therapy.

    Device: Rocking chair therapy

  • Active comparator
    Control intervention

    Control intervention is also transferred to the rocking chair, but the therapy program will not be turned on.

    Device: Rocking chair therapy

Interventions

  • DeviceRocking chair therapy

    20 min long rocking therapy with music cure. The therapy can be extended if needed

06

What researchers measure

Primary outcomes

  1. number of days alive without coma and delirium in the ICU

    Time frame: 14 day follow up

Secondary outcomes

  1. Number of days admitted to the ICU

    Time frame: 14 day follow up

  2. Delta RASS

    RASS score goes from +4 very agitated to -5 is coma. A score of 0 is equal to alert and calm

    Time frame: 14 day follow up

  3. all cause mortality

    all cause mortality at additional follow-up

    Time frame: 90 day follow up

07

Study locations

1 site
  • Copenhagen University Hospital, Rigshospitalet
    Copenhagen, 2100, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2020 to primary completion in Nov 2022, 29 months.

Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 29 months is above that.

Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2019
First posted
May 26, 2020
StartActual
Jun 1, 2020
Primary completionActual
Nov 13, 2022
CompletionActual
Nov 13, 2022
Last update
Mar 19, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04401514
Lead sponsor
Scandinavian Critical Care Trials Group
Responsible party
Anders Perner (Professor, Scandinavian Critical Care Trials Group) — Principal investigator
First posted
May 26, 2020
Start date
Jun 1, 2020
Primary completion
Nov 13, 2022
Completion
Nov 13, 2022
Last update
Mar 19, 2024

Study contacts

Ingrid Egerod, Professor
study chair · Department of Intensive care, Copenhagen University Hospital, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion